Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Neurology
Study Phase : Phase II/ Phase III
Recipient : Ethicon
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair
Details : Evicel (Fibrin Sealant) is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Dura Defects.
Product Name : Evicel
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 04, 2010
Lead Product(s) : Fibrin Sealant
Therapeutic Area : Neurology
Highest Development Status : Phase II/ Phase III
Recipient : Ethicon
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Human Fibrinogen
Therapeutic Area : Hematology
Study Phase : Phase III
Recipient : Ethicon
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Human Fibrinogen is a Protein drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hemorrhage.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
July 21, 2010
Lead Product(s) : Human Fibrinogen
Therapeutic Area : Hematology
Highest Development Status : Phase III
Recipient : Ethicon
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
